Impact of change in vancomycin-resistant Enterococcus infection prevention policy

To the Editor—Vancomycin-resistant Enterococcus (VRE) is a nosocomial pathogen of clinical importance, given increasing healthcare-associated infection rates since its discovery in 1988 and limited treatment options.1 A widely adopted infection control practice, recommended by the Centers for Diseas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection control and hospital epidemiology 2024-05, Vol.45 (5), p.691-692
Hauptverfasser:	Kiss, Christopher R., Ryan, Susan, Meyer, Jacky, Kotsanas, Despina, Cheng, Allen C., Stuart, Rhonda L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - therapeutic use Antibiotic resistance Bacterial Infections - drug therapy Colonization Cross Infection - drug therapy Disease control Enterococcus Enterococcus faecium Fecal incontinence Gram-Positive Bacterial Infections - prevention & control Health services Hospitals Humans Infections Intervention Letter to the Editor Nosocomial infection Pandemics Policy Prevention Surveillance Trends Vancomycin Vancomycin-Resistant Enterococci
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!